Connect with UMGCC
Email page
Print page
Email page
Print page
Loading
- Patient Care
- Being Admitted
- UMGCC Directory
- Schedule an Appointment
- Ask the Expert
- Patient Education
- Dictionary of Cancer Terms
- Parking, Lodging and Restaurants
- Podcasts
- Audio/Video Library
Related Resources- Center for Image Renewal
- Clinical Trials
- Contact Us
- Patient Web Pages
Home >Information for Patients > Dictionary Index
Dictionary of Cancer Terms
View in Spanish: Clorhidrato de erlotinib
Erlotinib hydrochloride (er-LOH-ty-nib HY-droh-KLOR-ide)
A drug used to treat certain types of non-small cell lung cancer. It is also used together with gemcitabine to treat pancreatic cancer and is being studied in the treatment of other types of cancer. Erlotinib hydrochloride is a type of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. Also called CP-358,774, erlotinib, OSI-774, and Tarceva.
Source: National Cancer Institute Dictionary of Cancer Terms, available at www.cancer.gov/dictionary.
Email this Page
Print this Page
If you would like to make an appointment or talk to someone about our services, please call 1-800-888-8823.
Physicians can call our dedicated consultation referral service at 1-800-373-4111.
Physicians can call our dedicated consultation referral service at 1-800-373-4111.
© 2011 University of Maryland Greenebaum Cancer Center. All rights reserved.
22 S. Greene Street, Baltimore, MD 21201
22 S. Greene Street, Baltimore, MD 21201
